⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
MPLT News
MapLight Therapeutics, Inc. Common Stock
MapLight Therapeutics Announces Changes to Board of Directors
globenewswire.com
MPLT
Form 8-K
sec.gov
MPLT
MapLight Announces Topline Results from Phase 2 IRIS Study for ML-004 in Autism Spectrum Disorder
globenewswire.com
MPLT
Form 8-K
sec.gov
MPLT
Form 8-K
sec.gov
MPLT
MapLight Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update
globenewswire.com
MPLT
MapLight Therapeutics to Participate in Upcoming Investor Conferences
globenewswire.com
MPLT
MapLight Therapeutics Announces Completion of Enrollment in ZEPHYR Phase 2 Trial and Updates Expected Timing of Topline Results
globenewswire.com
MPLT
Form 8-K
sec.gov
MPLT
Form 8-K
sec.gov
MPLT